Familial myeloid malignancies with germline TET2 mutation

Leukemia. 2020 May;34(5):1450-1453. doi: 10.1038/s41375-019-0675-6. Epub 2019 Dec 11.

Nicolas Duployez^{1

2}, Laure Goursaud³, Laurène Fenwarth^{4

5}, Claire Bories⁶, Alice Marceau-Renaut^{4

5}, Thomas Boyer^{4

5}, Elise Fournier^{4

7}, Olivier Nibourel^{4

5}, Catherine Roche-Lestienne^{5

8}, Guillemette Huet^{5

9}, David Beauvais³, Céline Berthon^{5

3}, Nathalie Cambier^{3

10}, Bruno Quesnel^{5

3}, Claude Preudhomme^{4

5}

¹ CHU Lille, Laboratory of Hematology, F-59000, Lille, France. nicolas.duployez@chru-lille.fr.
² INSERM, UMR-S 1172, F-59000, Lille, France. nicolas.duployez@chru-lille.fr.
³ CHU Lille, Department of Hematology, F-59000, Lille, France.
⁴ CHU Lille, Laboratory of Hematology, F-59000, Lille, France.
⁵ INSERM, UMR-S 1172, F-59000, Lille, France.
⁶ CH Lens, Department of Hematology, F-62307, Lens, France.
⁷ CH Dunkerque, Laboratory of Hematology, F-59385, Dunkerque, France.
⁸ CHU Lille, Department of Medical Genetics, F-59000, Lille, France.
⁹ CHU Lille, Cell Culture Department, F-59000, Lille, France.
¹⁰ CH Valenciennes, Department of Hematology, F-59322, Valenciennes, France.

No abstract available

Publication types